The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition
Open accessAbstract
The JAK/STAT3 signaling pathway plays an essential role in various types of cancers. Activation of this pathway leads to increased tumorigenic and metastatic ability, the transition of cancer stem cells (CSCs), and chemoresistance in cancer via enhancing the epithelial–mesenchymal transition (EMT). EMT acts as a critical regulator in the progression of cancer and is involved in regulating invasion, spread, and survival. Furthermore, accumulating evidence indicates the failure of conventional therapies due to the acquisition of CSC properties. In this review, we summarize the effects of JAK/STAT3 activation on EMT and the generation of CSCs. Moreover, we discuss cutting-edge data on the link between EMT and CSCs in the tumor microenvironment that involves a previously unknown function of miRNAs, and also discuss new regulators of the JAK/STAT3 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
Jiang, R., Zhang, C., Liu, G., Gu, R., & Wu, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26024 · Cited by 67
RetractedYousuf, S., Duan, M., Moen, E. L., Cross-Knorr, S., Brilliant, K. E., Bonavida, B., LaValle, T., Yeung, K. C., Al‐Mulla, F., Chin, E. Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092478 · Cited by 58
RetractedTao, Y., Yang, S., Wu, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21488 · Cited by 45
RetractedKim, M. S., Jeong, J., Seo, J., Kim, H.-S., Kim, S., & Jin, W. (2016) · Scientific Reports · doi:10.1038/srep33899 · Cited by 41
Self-citationRetractedGong, C., Shen, J., Fang, Z., Qiao, L., Feng, R., Lin, X., & Li, S. (2018) · Bioscience Reports · doi:10.1042/bsr20180532 · Cited by 35
RetractedDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“The JAK/STAT signaling pathway comprises of the receptor and adaptor proteins of interleukin 6 (IL-6), interferon-alpha (IFN-α), and interferon-gamma (IFN-γ) that mediate pleiotropic functions upon binding to their respective ligands [1,2].”
BackgroundSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 1×
“Upon binding IL-6, the IL-6 receptor-α (IL-6R) forms a complex with glycoprotein 130 (IL-6Rβ), and subsequently, triggers the activation of receptor-associated JAK1, JAK2, and tyrosine-protein kinase 2 (TYK2) pathways [4,5].”
BackgroundEMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
MET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,240
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Shuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., & Darnell, J. E. (1994) · Cell · doi:10.1016/0092-8674(94)90357-3 · Cited by 807
Kim, E., Kim, M., Woo, D.-H., Shin, Y., Shin, J., Chang, N., Oh, Y. T., Kim, H., Rheey, J., Nakano, I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.008 · Cited by 806
Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue
Yuan, Z.-L., Guan, Y.-J., Chatterjee, D., & Chin, Y. E. (2005) · Science · doi:10.1126/science.1105166 · Cited by 790
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753
Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.-C., Wulf, G., Rottapel, R., Yamaoka, S., & Lu, K. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00490-8 · Cited by 637
Lo, H.-W., Hsu, S.-C., Xia, W., Cao, X., Shih, J.-Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N., & Hung, M.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0575 · Cited by 625
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
Lo, H.-W., Hsu, S.-C., Ali-Seyed, M., Gunduz, M., Xia, W., Wei, Y., Bartholomeusz, G., Shih, J.-Y., & Hung, M.-C. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.007 · Cited by 544
Yadav, A., Kumar, B., Datta, J., Teknos, T. N., & Kumar, P. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0271 · Cited by 503
Contribution of STAT SH2 Groups to Specific Interferon Signaling by the Jak-STAT pathway
Heim, M. H., Kerr, L. M., Stark, G. R., & Darnell, J. E. (1995) · Science · doi:10.1126/science.7871432 · Cited by 425
STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425
Hes binding to STAT3 mediates crosstalk between Notch and JAK–STAT signalling
Kamakura, S., Oishi, K., Yoshimatsu, T., Nakafuku, M., Masuyama, N., & Gotoh, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1138 · Cited by 423
Zhang, H., Cai, K., Wang, J., Wang, X., Cheng, K., Shi, F., Jiang, L., Zhang, Y., & Dou, J. (2014) · Stem Cells · doi:10.1002/stem.1795 · Cited by 368
A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
Gujral, T. S., Chan, M., Peshkin, L., Sorger, P. K., Kirschner, M. W., & MacBeath, G. (2014) · Cell · doi:10.1016/j.cell.2014.10.032 · Cited by 350
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347
Davis, F. M., Azimi, I., Faville, R. A., Peters, A. A., Jalink, K., Putney, J. W., Goodhill, G. J., Thompson, E. W., Roberts-Thomson, S. J., & Monteith, G. R. (2014) · Oncogene · doi:10.1038/onc.2013.187 · Cited by 333
The molecular regulation of Janus kinase (JAK) activation
Babon, J. J., Lucet, I. S., Murphy, J. M., Nicola, N. A., & Varghese, L. N. (2014) · Biochemical Journal · doi:10.1042/bj20140712 · Cited by 326
Osteopontin: regulation in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9104-9 · Cited by 321
Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., Ackland, L., & Ahmed, N. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604794 · Cited by 320
Fuchs, B. C., Fujii, T., Dorfman, J. D., Goodwin, J. M., Zhu, A. X., Lanuti, M., & Tanabe, K. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2460 · Cited by 309
Xiong, H., Hong, J., Du, W., Lin, Y.-W., Ren, L.-L., Wang, Y.-C., Su, W.-Y., Wang, J.-L., Cui, Y., Wang, Z.-H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 307
PRC2 directly methylates GATA4 and represses its transcriptional activity
He, A., Shen, X., Ma, Q., Cao, J., von Gise, A., Zhou, P., Wang, G., Marquez, V. E., Orkin, S. H., & Pu, W. T. (2012) · Genes & Development · doi:10.1101/gad.173930.111 · Cited by 291
Troussard, A. A., Mawji, N. M., Ong, C., Mui, A., St.-Arnaud, R., & Dedhar, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303083200 · Cited by 276
Feng, Y., Ke, C., Tang, Q., Dong, H., Zheng, X., Lin, W., Ke, J., Huang, J., Yeung, S.-C., & Zhang, H. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.59 · Cited by 272
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Zhou, X. Z., & Lu, K. P. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.49 · Cited by 266
Zhang, Q., Wang, H. Y., Marzec, M., Raghunath, P. N., Nagasawa, T., & Wasik, M. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501959102 · Cited by 262
EZH2 Generates a Methyl Degron that Is Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase Complex
Lee, J. M., Lee, J. S., Kim, H., Kim, K., Park, H., Kim, J.-Y., Lee, S. H., Kim, I. S., Kim, J., Lee, M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.004 · Cited by 247
Izumi, K., Fang, L., Mizokami, A., Namiki, M., Li, L., Lin, W., & Chang, C. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202367 · Cited by 247
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., & Yoshimura, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209281 · Cited by 246
Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., Zhang, R., Zhang, B., & Feng, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0176-3 · Cited by 243
Hemmann, U., Gerhartz, C., Heesel, B., Sasse, J., Kurapkat, G., Grötzinger, J., Wollmer, A., Zhong, Z., Darnell, J. E., Graeve, L., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12999 · Cited by 239
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
Bockhorn, J., Dalton, R., Nwachukwu, C., Huang, S., Prat, A., Yee, K., Chang, Y.-F., Huo, D., Wen, Y., Swanson, K. E., et al. (2013) · Nature Communications · doi:10.1038/ncomms2393 · Cited by 237
Jaks and cytokine receptors—An intimate relationship
Haan, C., Kreis, S., Margue, C., & Behrmann, I. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.013 · Cited by 229
Interacting Regions in Stat3 and c-Jun That Participate in Cooperative Transcriptional Activation
Zhang, X., Wrzeszczynska, M. H., Horvath, C. M., & Darnell, J. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7138 · Cited by 225
Regulation of STAT3 by Direct Binding to the Rac1 GTPase
Simon, A. R., Vikis, H. G., Stewart, S., Fanburg, B. L., Cochran, B. H., & Guan, K.-L. (2000) · Science · doi:10.1126/science.290.5489.144 · Cited by 224
Guo, L., Chen, C., Shi, M., Wang, F., Chen, X., Diao, D., Hu, M., Yu, M., Qian, L., & Guo, N. (2013) · Oncogene · doi:10.1038/onc.2012.573 · Cited by 209
Jung, M.-J., Rho, J.-K., Kim, Y.-M., Jung, J. E., Jin, Y. B., Ko, Y.-G., Lee, J.-S., Lee, S.-J., Lee, J. C., & Park, M.-J. (2013) · Oncogene · doi:10.1038/onc.2012.37 · Cited by 201
Shiota, M., Bishop, J. L., Nip, K. M., Zardan, A., Takeuchi, A., Cordonnier, T., Beraldi, E., Bazov, J., Fazli, L., Chi, K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3979 · Cited by 194
Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
Kim, M., Morales, L. D., Jang, I.-S., Cho, Y.-Y., & Kim, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092708 · Cited by 176
Direct reprogramming of stem cell properties in colon cancer cells by CD44
Su, Y., Lai, H., Chang, Y., Chen, G., & Lee, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.211 · Cited by 174
Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
Chen, Y., Wu, Y., Yang, H., Li, X., Jie, M., Hu, C.-J., Wu, Y., Yang, S., & Yang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0844-y · Cited by 173
MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells
Liu, S., Patel, S. H., Ginestier, C., Ibarra, I., Martin-Trevino, R., Bai, S., McDermott, S. P., Shang, L., Ke, J., Ou, S. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002751 · Cited by 166
Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
Lee, J.-L., Wang, M.-J., & Chen, J.-Y. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200812060 · Cited by 164
Sarris, M. E., Moulos, P., Haroniti, A., Giakountis, A., & Talianidis, I. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.013 · Cited by 161
Kong, X., Chen, J., Xie, W., Brown, S. M., Cai, Y., Wu, K., Fan, D., Nie, Y., Yegnasubramanian, S., Tiedemann, R. L., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.003 · Cited by 161
Li, H., Rokavec, M., Jiang, L., Horst, D. A., & Hermeking, H. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.017 · Cited by 160
Mattos‐Arruda, L. D., Bottai, G., Nuciforo, P. G., Tommaso, L. D., Giovannetti, E., Peg, V., Losurdo, A., Pérez-García, J. M., Masci, G., Corsi, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5495 · Cited by 159
Güngör, C., Zander, H., Effenberger, K. E., Vashist, Y. K., Kalinina, T., Izbicki, J. R., Yekebas, E. F., & Bockhorn, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0036 · Cited by 157
IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR
Rojas, A., Liu, G., Coleman, I., Nelson, P. S., Zhang, M., Dash, R., Fisher, P. B., Plymate, S. R., & Wu, J. D. (2011) · Oncogene · doi:10.1038/onc.2010.605 · Cited by 155
MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3
Fan, Z., Cui, H., Xu, X., Lin, Z., Zhang, X., Kang, L., Han, B., Meng, J., Yan, Z., Yan, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4457 · Cited by 152
Liu, H., Ren, G., Wang, T., Chen, Y., Gong, C., Bai, Y., Wang, B., Qi, H., Shen, J., Zhu, L., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv017 · Cited by 151
Zhang, T., Kee, W. H., Seow, K. T., Fung, W., & Cao, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7132-7139.2000 · Cited by 150
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions
Ferrao, R., & Lupardus, P. J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00071 · Cited by 150
Zhau, H. E., Odero-Marah, V., Lue, H.-W., Nomura, T., Wang, R., Chu, G. C., Liu, Z., Zhou, B. P., Huang, W., & Chung, L. W. K. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9183-1 · Cited by 149
Rac1 mediates STAT3 activation by autocrine IL-6
Faruqi, T. R., Gomez, D., Bustelo, X. R., Bar‐Sagi, D., & Reich, N. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161281298 · Cited by 149
Högstrand, C., Kille, P., Ackland, M. L., Hiscox, S., & Taylor, K. M. (2013) · Biochemical Journal · doi:10.1042/bj20130483 · Cited by 147
Yue, P., Zhang, X., Paladino, D., Sengupta, B., Ahmad, S., Holloway, R. W., Ingersoll, S. B., & Turkson, J. (2011) · Oncogene · doi:10.1038/onc.2011.409 · Cited by 140
Lü, M., Lu, L., Dong, Q., Yu, G., Chen, J., Qin, L., Wang, L.-X., Zhu, W., & Jia, H. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy009 · Cited by 138
Ahmad, R., Kumar, B., Chen, Z., Chen, X., Müller, D., Lele, S. M., Washington, M. K., Batra, S. K., Dhawan, P., & Singh, A. B. (2017) · Oncogene · doi:10.1038/onc.2017.259 · Cited by 137
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
Junk, D. J., Bryson, B. L., Smigiel, J. M., Parameswaran, N., Bartel, C. A., & Jackson, M. W. (2017) · Oncogene · doi:10.1038/onc.2017.33 · Cited by 134
STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination
Jung, J. E., Kim, H. S., Lee, C. S., Shin, Y., Kim, Y.-N., Kang, G. H., Kim, T.-Y., Juhnn, Y., Kim, S. J., Park, J., et al. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.5.479 · Cited by 128
Yao, C., Su, L., Shan, J., Zhu, C., Liu, L., Liu, C., Xu, Y., Yang, Z., Bian, X., Shao, J., et al. (2016) · Stem Cells · doi:10.1002/stem.2320 · Cited by 123
Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
Kothari, A. N., Arffa, M., Chang, V. A., Blackwell, R. H., Syn, W., Zhang, J., Mi, Z., & Kuo, P. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040039 · Cited by 121
Zhao, S., Venkatasubbarao, K., Lazor, J. W., Sperry, J. C., Jin, C., Cao, L., & Freeman, J. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5123 · Cited by 120
STAT3 mediates TGF-β1-induced TWIST1 expression and prostate cancer invasion
Cho, K. H., Jeong, K. J., Shin, S. C., Kang, J., Park, C. G., & Lee, H. Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.024 · Cited by 117
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Das, R., Gregory, P. A., Fernandes, R. C., Denis, I., Wang, Q., Townley, S. L., Zhao, S. G., Hanson, A. R., Pickering, M. A., Armstrong, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2529 · Cited by 117
Ming-li, H., Liu, M., Wang, Y., Mo, Z., Bi, X., Liu, Z., Fan, Y., Chen, X., & Wu, C. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1195-5 · Cited by 115
CD44 Engagement Promotes Matrix-Derived Survival through the CD44-SRC-Integrin Axis in Lipid Rafts
Lee, J.-L., Wang, M.-J., Sudhir, P., & Chen, J.-Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00186-08 · Cited by 114
Kelber, J. A., Reno, T. A., Kaushal, S., Metildi, C. A., Wright, T., Stoletov, K. V., Weems, J. M., Park, F. D., Mose, E. S., Wang, Y., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3552 · Cited by 114
STAT3 selectively interacts with Smad3 to antagonize TGF-β
Wang, G., Yu, Y., Sun, C., Liu, T., Liang, T., Zhan, L., Lin, X., & Feng, X.-H. (2015) · Oncogene · doi:10.1038/onc.2015.446 · Cited by 113
MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1
Chen, C. A., Chang, J. T., Ho, Y.-F., & Shyu, A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw205 · Cited by 109
STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression
Saitoh, M., Endo, K., Furuya, S., Minami, M., Fukasawa, A., Imamura, T., & Miyazawa, K. (2015) · Oncogene · doi:10.1038/onc.2015.161 · Cited by 108
CHUNG, S. S., Aroh, C., & Vadgama, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083971 · Cited by 108
Wani, N. A., Nasser, M. W., Ahirwar, D. K., Zhao, H., Miao, Z., Shilo, K., & Ganju, R. K. (2014) · Breast Cancer Research · doi:10.1186/bcr3665 · Cited by 108
Kim, M. S., Lee, W. S., Jeong, J., Kim, S., & Jin, W. (2015) · Oncotarget · doi:10.18632/oncotarget.5522 · Cited by 108
Self-citationLee, K., Hsu, E., Guh, J., Yang, M., Wang, D.-S., Kulp, S. K., Shapiro, C. L., & Chen, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264598 · Cited by 107
Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity
Lufei, C., Koh, T. H., Uchida, T., & Cao, X. (2007) · Oncogene · doi:10.1038/sj.onc.1210567 · Cited by 106
MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop
Ahmad, R., Rajabi, H. N., Kosugi, M., Joshi, M. D., Alam, M., Vasir, B., Kawano, T., Kharbanda, S. M., & Kufe, D. W. (2011) · Science Signaling · doi:10.1126/scisignal.2001426 · Cited by 106
Wang, Y., Fu, D., Chen, Y., Su, J., Wang, Y., Li, X., Zhai, W., Niu, Y., Yue, D., & Geng, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0504-2 · Cited by 105
Lin, C., Yeh, H.-H., Huang, W.-L., Yan, J.-J., Lai, W., Su, W., Chen, H. H. W., & Su, W. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0244oc · Cited by 104
Azimi, I., Milevskiy, M. J. G., Kaemmerer, E., Turner, D., Yapa, K. T. D. S., Brown, M. A., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2017) · Journal of Cell Science · doi:10.1242/jcs.196659 · Cited by 104
Yang, Z., Guo, L., Liu, D., Sun, L., Chen, H., Deng, Q., Liu, Y., Yu, M., Yuan-fang Ma, A., Guo, N., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3241 · Cited by 102
Cho, K. H., Choi, M., Jeong, K. J., Kim, J. J., Hwang, M. H., Shin, S. C., Park, C. G., & Lee, H. Y. (2014) · The Prostate · doi:10.1002/pros.22776 · Cited by 98
Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells
Wang, T., Yuan, J., Zhang, J., Tian, R., Ji, W., Zhou, Y., Yang, Y., Song, W., Zhang, F., & Niu, R. (2015) · Oncotarget · doi:10.18632/oncotarget.5199 · Cited by 97
Yue, W., Zheng, X., Lin, Y., Yang, C. S., Xu, Q., Carpizo, D. R., Huang, H., DiPaola, R. S., & Tan, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4126 · Cited by 96
Hendrayani, S., Al‐Khalaf, H. H., & Aboussekhra, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594044 · Cited by 96
Oestrogen-regulated genes in breast cancer: Association of pLIV1 with lymph node involvement
Manning, D. L., Robertson, J. F. R., Ellis, I. O., Elston, C. W., McClelland, R. A., Gee, J. M. W., Jones, R. J., Green, C. D., Cannon, P., Blamey, R. W., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90543-6 · Cited by 96
Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Smigiel, J. M., Parameswaran, N., & Jackson, M. W. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0337 · Cited by 96
Lahsnig, C., Mikula, M., Petz, M., Zulehner, G., Schneller, D., van Zijl, F., Huber, H., Csiszar, A., Beug, H., & Mikulits, W. (2008) · Oncogene · doi:10.1038/onc.2008.418 · Cited by 95
Verma, N., Keinan, O., Selitrennik, M., Karn, T., Filipits, M., & Lev, S. (2015) · Nature Communications · doi:10.1038/ncomms7064 · Cited by 92
Involvement of Lyn and the Atypical Kinase SgK269/PEAK1 in a Basal Breast Cancer Signaling Pathway
Croucher, D. R., Hochgräfe, F., Zhang, L., Liu, L., Lyons, R. J., Rickwood, D., Tactacan, C. M., Browne, B. C., Ali, N., Chan, H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1472 · Cited by 92
Wu, C., Hsieh, C., Lin, C., Chen, W., Hong, J., & Chen, M. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0916-x · Cited by 91
Rocha, M. R., Barcellos‐de‐Souza, P., Squiavinato, A. C. M. S., Fernandes, P. V., de Oliveira, I. M., Boroni, M., & Morgado‐Díaz, J. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29703-0 · Cited by 91
Zhang, P., Bai, H., Liu, G., Wang, H., Chen, F., Zhang, B., Zeng, P., Wu, C., Peng, C., Huang, C., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.02.018 · Cited by 90
EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours
Bornachea, O., Santos, M., Martínez‐Cruz, A. B., García‐Escudero, R., Dueñas, M., Costa, C., Segrelles, C., Lorz, C., Buitrago, A., Sáiz-Ladera, C., et al. (2012) · Scientific Reports · doi:10.1038/srep00434 · Cited by 89
TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis
Woosley, A. N., Dalton, A. C., Hussey, G. S., Howley, B. V., Mohanty, B. K., Grelet, S., Dincman, T. A., Bloos, S. M., Olsen, S. K., & Howe, P. H. (2019) · Oncogene · doi:10.1038/s41388-019-0703-z · Cited by 89
Huang, Y., Hoque, M. O., Wu, F., Trink, B., Sidransky, D., & Ratovitski, E. A. (2008) · Cell Cycle · doi:10.4161/cc.7.11.5952 · Cited by 88
Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling
Wang, G., Yu, Y., Sun, C., Liu, T., Liang, T., Zhan, L., Lin, X., & Feng, X.-H. (2016) · Oncogene · doi:10.1038/onc.2016.145 · Cited by 88
Zhang, W., Qian, P., Zhang, X., Zhang, M., Wang, H., Wu, M., Kong, X., Tan, S. H., Ding, K., Perry, J. K., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653261 · Cited by 86
Wang, J., Yin, D., Xie, C., Zheng, T., Liang, Y., Hong, X., Lu, Z., Song, X., Song, R., Yang, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2328 · Cited by 82
Role of chemokine receptor CXCR7 in bladder cancer progression
Hao, M., Zheng, J., 侯恺林, Wang, J., Chen, X., Lu, X., 卜, 军., Xu, C., Shen, K., & Wang, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.007 · Cited by 82
Vitale, G., Zappavigna, S., Marra, M., Dicitore, A., Meschini, S., Condello, M., Arancia, G., Castiglioni, S., Maroni, P., Bendinelli, P., et al. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.08.001 · Cited by 82
Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction
Yue, X., Zhao, Y., Zhang, C., Li, J., Liu, Z., Liu, J., & Hu, W. (2015) · Oncotarget · doi:10.18632/oncotarget.6756 · Cited by 82
Wu, J., Wang, Y., Xi Tao, X. U., Cao, H., Sahengbieke, S., Sheng, H., Huang, Q., & Lai, M. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw029 · Cited by 80
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation
Gao, X., Liu, X., Lu, Y., Wang, Y., Cao, W., Liu, X., Hu, H., & Wang, H. (2019) · Breast Cancer · doi:10.1007/s12282-019-00966-3 · Cited by 80
Shvab, A., Haase, G., Ben‐Shmuel, A., Gavert, N. S., Brabletz, T., Dedhar, S., & Ben‐Ze'ev, A. (2015) · Oncogene · doi:10.1038/onc.2015.127 · Cited by 77
Yu, M., Xue, H., Wang, Y., Shen, Q., Jiang, Q., Zhang, X., Li, K., Jia, M., Jia, J.-K., Xu, J. M., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3852 · Cited by 77
MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors
Kitamoto, S., Yokoyama, S., Higashi, M., Yamada, N., Takao, S., & Yonezawa, S. (2012) · Oncogene · doi:10.1038/onc.2012.478 · Cited by 76
Gao, H., Teng, C.-Y., Huang, W., Peng, J.-J., & Wang, C.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921643 · Cited by 76
Teng, K., Wei, S., Zhang, C., Chen, J., Chen, J., Xiao, K., Liu, J., Dai, M., Guan, X., Yun, J., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1331-8 · Cited by 76
Pollack, V., Sárközi, R., Bánki, Z., Feifel, E., Wehn, S., Gstraunthaler, G. J. A., Stoiber, H., Mayer, G. J., Montesano, R., Strutz, F. M., et al. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00130.2007 · Cited by 75
Chen, W., Gao, Q., Han, S., Pan, F., & Fan, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-2717-z · Cited by 74
MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer
Eyking, A., Reis, H., Frank, M., Gerken, G., Schmid, K. W., & Cario, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156871 · Cited by 74
Luo, F., Xu, Y., Ling, M., Zhao, Y., Xu, W., Xiao, L., Jiang, R., Wang, B., Bian, Q., & Liu, Q. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.025 · Cited by 73
Sun, S.-S., Zhou, X., Huang, Y.-Y., Kong, L.-P., Mei, M., Guo, W.-Y., Zhao, M.-H., Ren, Y., Shen, Q., & Zhang, L. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0487-x · Cited by 72
Zhou, K., Rao, J., Zhou, Z.-H., Yao, X.-H., Wu, F., Yang, J., Yang, L., Zhang, X., Cui, Y., Bian, X., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0071-2 · Cited by 70
Lin, X., Lin, B., Chen, X.-L., Zhang, B., Xiao, X.-J., Shi, J.-S., Lin, J.-D., & Chen, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.014 · Cited by 67
Ma, Y., Zhang, H., Xiong, C., Liu, Z., Xu, Q., Feng, J., Zhang, J., Wang, Z., & Yan, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.016 · Cited by 67
Kim, M.-J., Lim, J., Yang, Y., Lee, M., & Lim, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.023 · Cited by 66
Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity
Hu, T., Yeh, J., Pinello, L., Jacob, J., Chakravarthy, S., Yuan, G., Chopra, R., & Frank, D. A. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00060-15 · Cited by 66
Yang, S., Yang, C., Yu, F., Ding, W., Hu, Y., Cheng, F., Zhang, F., Guan, B., Wang, X., Lu, L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1134-4 · Cited by 66
Souma, Y., Nishida, T., Serada, S., Iwahori, K., Takahashi, T., Fujimoto, M., Ripley, B., Nakajima, K., Miyazaki, Y., Mori, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27350 · Cited by 65
Liu, X., Zhang, X., Meng, J., Zhang, H.-F., Zhao, Y., Li, C., Sun, Y., Mei, Q., Zhang, F., & Zhang, T. (2017) · Oncotarget · doi:10.18632/oncotarget.17346 · Cited by 65
Bizzarro, V., Belvedere, R., Milone, M. R., Pucci, B., Lombardi, R., Bruzzese, F., Popolo, A., Parente, L., Budillon, A., & Petrella, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4725 · Cited by 64
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
Esparza‐López, J., Alvarado-Muñoz, J. F., Escobar-Arriaga, E., Ulloa‐Aguirre, A., & Ibarra-Sánchez, M. D. J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5945-1 · Cited by 64
Wei, J.-H., Cao, J.-Z., Zhang, D., Liao, B., Zhong, W.-M., Lu, J. K., Zhao, H.-W., Zhang, J.-X., Tong, Z.-T., Fan, S., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.52 · Cited by 63
Ratovitski, E. A., Kotzbauer, P. T., Milbrandt, J., Lowenstein, C. J., & Burrow, C. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3654 · Cited by 62
Satoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000394 · Cited by 62
miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1
Dang, W., Qin, Z., Fan, S., Wen, Q., Lu, Y., Wang, J., Zhang, X., Wei, L., He, W., Ye, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8718 · Cited by 62
Meng, J., Zhang, X., Liu, X., Fan, L., Li, C., Sun, Y., Liang, X., Wang, J., Mei, Q., Zhang, F., et al. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.07.008 · Cited by 61
Kahata, K., Hayashi, M., Asaka, M., Hellman, U., Kitagawa, H., Yanagisawa, J., Kato, S., Imamura, T., & Miyazono, K. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00706.x · Cited by 60
Shi, P., Lai, R. L., Lin, Q. D., et al. (2009) · Blood · doi:10.1182/blood-2007-11-125658 · Cited by 60
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy
Huang, T., Su, J.-C., Liu, C., Shiau, C., & Chen, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061234 · Cited by 60
Caraglia, M., Tagliaferri, P., Marra, M., Giuberti, G., Budillon, A., Gennaro, E. D., Pepe, S., Vitale, G., Improta, S., Tassone, P., et al. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401131 · Cited by 59
Ryan, R. E., Martin, B. T., Mellor, L. F., Jacob, R. B., Tawara, K., McDougal, O. M., Oxford, J. T., & Jorcyk, C. L. (2015) · Cytokine · doi:10.1016/j.cyto.2014.11.007 · Cited by 58
Park, J. S., Choi, S. Y., Lee, J.-H., Lee, M., Nam, E. S., Jeong, A. L., Lee, S., Han, S., Lee, M. S., Lim, J., et al. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0154-4 · Cited by 58
Tactacan, C. M., Phua, Y. W., Liu, L., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0412-3 · Cited by 58
Erratum: Corrigendum: IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2017) · Nature Immunology · doi:10.1038/ni1117-1271b · Cited by 57
Albino, D., Civenni, G., Rossi, S., Mitra, A., Catapano, C. V., & Carbone, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.12525 · Cited by 56
Gui, Y., Yeganeh, M., Donates, Y.-C., Tobelaim, W.-S., Chababi, W., Mayhue, M., Yoshimura, A., Ramanathan, S., Saucier, C., & Ilangumaran, S. (2015) · Oncogene · doi:10.1038/onc.2015.20 · Cited by 55
Uddin, N., Kim, R., Yoo, K.-C., Kim, Y., Cui, Y., Kim, I., Suh, Y., & Lee, S. (2015) · Cancer Science · doi:10.1111/cas.12668 · Cited by 53
Neuwirt, H., Puhr, M., Cavarretta, I. T. R., Mitterberger, M., Hobisch, A., & Čulig, Z. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0172 · Cited by 52
Chen, J., Lan, T., Zhang, W., Dong, L., Kang, N., Zhang, S., Fu, M., Liu, B., Liu, K., & Zhan, Q. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1062 · Cited by 52
Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn
Li, C., & Götz, J. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180054 · Cited by 52
Zhao, G., Nie, Y., Lv, M., He, L., Wang, T., & Hou, Y. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1028 · Cited by 51
Repression of microRNA-130b by thyroid hormone enhances cell motility
Lin, Y.-H., Wu, M., Liao, C., Huang, Y., Chi, H., Wu, S.-M., Chen, C.-Y., Tseng, Y., Tsai, C., Chung, I., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.035 · Cited by 51
Kucia-Tran, J., Tulkki, V., Smith, S. P., Scarpini, C. G., Hughes, K., Araujo, A. M., Yan, K. Y. M., Botthof, J. G., Pérez-Gómez, E., Quintanilla, M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.199 · Cited by 51
Establishment of a TGFβ-Induced Post-Transcriptional EMT Gene Signature
Hussey, G. S., Link, L. A., Brown, A. S., Howley, B. V., Chaudhury, A., & Howe, P. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052624 · Cited by 49
Qian, H., Chen, Y., & Yang, Y. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.28 · Cited by 49
Zhang, J., Chu, D., Kawamura, T., Tanaka, K., & He, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27914 · Cited by 49
Wang, T., Lin, F., Sun, X., Jiang, L., Mao, R., Zhou, S., Shang, W., Bi, R., Lu, F., & Li, S. (2019) · Cancer Cell International · doi:10.1186/s12935-018-0717-6 · Cited by 49
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
Bryson, B. L., Junk, D. J., Cipriano, R., & Jackson, M. W. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1259037 · Cited by 48
Chen, J., Wang, S., Su, J., Chu, G., You, H., Chen, Z., Chen, B., Zhou, M., & Sun, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s103581 · Cited by 47
Leng, K., Xu, Y., Kang, P., Qin, W., Cai, H., Wang, H., Ji, D., Jiang, X., Li, J., Li, Z., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1506-4 · Cited by 47
Pan, X., Wang, X., Lei, W., Min, L., Yang, Y., Wang, X., & Song, J. (2009) · Hepatology · doi:10.1002/hep.23156 · Cited by 46
Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells
Kwon, T., Bak, Y., Park, Y., Jang, G.-B., Nam, J., Yoo, J. E., Park, Y. N., Bak, I. S., Kim, J., Yoon, D., et al. (2016) · Stem Cells · doi:10.1002/stem.2323 · Cited by 46
Zhao, Y., Ma, K., Yang, S., Zhang, X., Wang, F., Zhang, X., Liu, H., & Fan, Q. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4409 · Cited by 45
Function of GCN5 in the TGF‑β1‑induced epithelial‑to‑mesenchymal transition in breast cancer
Zhao, L., Pang, A., & Li, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9134 · Cited by 43
Involvement of JAK2 upstream of the PI 3-kinase in cell–cell adhesion regulation by gastrin
Ferrand, A., Kowalski‐Chauvel, A., Bertrand, C., Pradayrol, L., Fourmy, D., Dufresne, M., & Seva, C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.037 · Cited by 41
Bak, Y., Kwon, T., Bak, I. S., Hong, J. T., Yu, D., & Yoon, D. (2016) · Oncotarget · doi:10.18632/oncotarget.7007 · Cited by 41
Al‐Khalaf, H. H., Ghebeh, H., Inass, R., & Aboussekhra, A. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00359-18 · Cited by 41
Boccellino, M., Giuberti, G., Quagliuolo, L., Marra, M., D’Alessandro, A. M., Fujita, H., Giovane, A., Abbruzzese, A., & Caraglia, M. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20058 · Cited by 40
Avalle, L., Incarnato, D., Savino, A., Gai, M., Marino, F., Pensa, S., Barbieri, I., Stadler, M. B., Provero, P., Oliviero, S., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.103 · Cited by 40
Ai, M., Liang, K., Lü, Y., Qiu, S., & Fan, Z. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23295 · Cited by 39
Wu, K., Shen, B. Q., Jiang, F., Xia, L., Fan, T., Qin, M., Yang, L., Guo, J., Li, Y., Zhu, M., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447914 · Cited by 39
Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation
Liu, J., Qu, X., Shao, L., Hu, Y., Yu, X., Lan, P., Guo, Q., Han, Q., Zhang, J., & Zhang, C. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1414756 · Cited by 39
Zhu, Z., Wang, S., Zhu, J., Yang, Q., Dong, H., & Huang, J. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0104 · Cited by 38
Thyrell, L., Arulampalam, V., Hjortsberg, L., Farnebo, M., Grandér, D., & Tamm, K. P. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.08.007 · Cited by 37
Huang, S., Liu, Q., Liao, Q., Wu, Q., Sun, B., Yang, Z., Hu, X., Tan, M., & Li, L. (2017) · Cancer Science · doi:10.1111/cas.13493 · Cited by 37
Liu, X., Meng, J., Zhang, X., Liang, X., Zhang, F., Zhao, G., & Zhang, T. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13013 · Cited by 37
Tang, J., Kong, X., Banerjee, A., Muniraj, N., Pandey, V., Steiner, M., Perry, J. K., Zhu, T., Liu, D., & Lobie, P. E. (2010) · Endocrinology · doi:10.1210/en.2010-0273 · Cited by 36
He, Q., Yi, H.-M., Yi, H. L., Xiao, T., Qu, J., Li, Y., Zhu, J.-F., Li, J.-Y., Wang, Y.-Y., Li, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3847 · Cited by 36
A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer
Muñoz-Rojas, A. R., Zhang, P., Wang, Y., Foo, W. C., Muñoz, N. M., Xiao, L., Wang, J., Gores, G. J., Hung, M., & Blechacz, B. R. A. (2016) · Neoplasia · doi:10.1016/j.neo.2016.04.002 · Cited by 35
MicroRNAs Provide Feedback Regulation of Epithelial‐Mesenchymal Transition Induced by Growth Factors
Qin, Z., He, W., Tang, J., Ye, Q., Dang, W., Lu, Y., Wang, J., Li, G., Yan, Q., & Ma, J. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25060 · Cited by 34
Zhou, Y., Zhang, Z., Wang, N., Chen, J., Zhang, X., Guo, M., Li, J. Z., & Wang, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0457-5 · Cited by 33
Adewuyi, E. E., Lopez-Campistrous, A., Tang, X., Brindley, D. N., & McMullen, T. P. W. (2016) · Oncotarget · doi:10.18632/oncotarget.13299 · Cited by 31
Xu, X., Yang, C., Chen, J., Liu, J., Li, P., Shi, Y., & Yu, P.-W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.144 · Cited by 31
Zhang, J., Wang, P., Wu, F., Li, M., Sharon, D. M., Ingham, R. J., Hitt, M., McMullen, T. P. W., & Lai, R. L. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.020 · Cited by 30
Li, T., Li, M., Hu, S., Cheng, X. C., Gao, Y., Jiang, S., Yu, Q., Zhang, C., Sun, P., Xian, W., et al. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.05.108 · Cited by 30
Zhao, L., Li, X., Song, N., Li, A., Hou, K., Qu, X., Che, X., & Liu, Y. (2017) · Cell Biology International · doi:10.1002/cbin.10894 · Cited by 29
Ji, P., Wang, L., Liu, J., Mao, P., Li, R., Jiang, H., Lou, M., Xu, M. M., & Yu, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27592 · Cited by 29
Sun, L., Feng, L., & Cui, J. (2018) · Diagnostic Pathology · doi:10.1186/s13000-018-0749-1 · Cited by 29
Role of DNA methyltransferase 1 in hormone-resistant prostate cancer
Chen, M., Chen, W., Chang, Y., Wu, C.-F., & Wu, C. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0640-3 · Cited by 28
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
Chen, C., Chang, W.-H., Su, K., Ku, W., Chang, G.-C., Hong, Q.-S., Hsiao, Y.-J., Chen, H.-C., Chen, H.-Y., Wu, R., et al. (2016) · Oncogene · doi:10.1038/onc.2016.106 · Cited by 28
Pavone, L. M., Cattaneo, F., Rea, S., Pasquale, V. D., Spina, A., Sauchelli, E., Mastellone, V., & Ammendola, R. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.005 · Cited by 27
Cited by
The role of IL-6/JAK2/STAT3 signaling pathway in cancers
Huang, B., Lang, X., & Li, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1023177 · Cited by 479
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.-S., Zeng, J., Mei, J., & Wang, P.-Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1110765 · Cited by 339
Song, Q., Zhang, X., Liu, W., Wei, H., Liang, W., Zhou, Y., Ding, Y., Ji, F., Ho-Kwan Cheung, A., Wong, N., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.005 · Cited by 293
Rho GTPase signaling in cancer progression and dissemination
Crosas-Molist, E., Samain, R., Kohlhammer, L., Orgaz, J. L., George, S. L., Maiques, O., Barcelo, J., & Sanz-Moreno, V. (2022) · Physiological Reviews · doi:10.1152/physrev.00045.2020 · Cited by 272
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
Hu, Y., Dong, Z., & Liu, K. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02949-5 · Cited by 268
Metadata
- Authors
- Jin, W.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-01-15
- Volume
- 9
- Issue
- 1
- Pages
- 217
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3000361261
- Cited by
- 496
- References
- 208
- FWCI
- 22.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.